Abstract
Reactivation of latent BK polyomavirus (BKV) infection continues to be a major challenge in renal graft recipients. Progression of BKV infection to BKV-associated nephropathy (BKVAN) leads to graft loss in up to 60% of affected patients. Interestingly, although >80% of healthy adults are seropositive for BKV, BKVAN occurs almost exclusively in transplanted kidneys, which raises questions about its underlying pathogenetic mechanisms. Intragraft inflammation and an insufficient antiviral immune response seem to be the most important risk factors. Early studies revealed an association between the rate of recovery of BKV-specific cellular immunity (which shows high interindividual variation) and BK viral clearance, which determines the clinical course of BKV infection. In patients with prompt recovery of BKV-specific T cells, BKV infection can be controlled at the early reactivation stage and does not progress to BKVAN. By contrast, in patients with persistent BKV reactivation caused by insufficient BKV-specific immunity, continued viral replication and inflammation ultimately lead to graft injury and/or BKVAN. As the chronic course of BKV infection can be prevented in most patients by prompt restoration of BKV-specific immunity, frequent monitoring of BK viral load and targeted, timely modification or reduction of immunosuppression is strongly recommended for affected patients.
Key Points
-
BK polyomavirus (BKV) is a latent virus known to reactivate under immunosuppression
-
BKV-associated nephropathy (BKVAN) is a complication of active BKV infection that mainly affects renal transplant recipients
-
Intragraft inflammation and an insufficient antiviral immune response seem to be the most important risk factors for BKVAN
-
No effective, specific therapy for BKVAN currently exists
-
Frequent monitoring of BKV replication followed by judicious reduction or modification of immunosuppression (to improve antiviral immunity) is the current recommended approach for management of BKVAN
-
An immune pathogenesis might dominate in patients with persistent BKV replication; reduction of immunosuppression as a therapeutic option for BKVAN should therefore be considered with caution in such patients
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Imperiale, M. J. & Major, E. O. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2263–2298 (Lippincott Williams & Wilkins, Philadelphia, 2007).
Bollag, B., Chuke, W. F. & Frisque, R. J. Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation. J. Virol. 63, 863–872 (1989).
Goudsmit, J. et al. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J. Med. Virol. 10, 91–99 (1982).
Polo, C. et al. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin. Microbiol. Infect. 10, 640–644 (2004).
Zhong, S. et al. Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. J. Clin. Microbiol. 45, 193–198 (2007).
Egli, A. et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis. 199, 837–846 (2009).
Hirsch, H. H. et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 347, 488–496 (2002).
Ramos, E., Drachenberg, C. B., Wali, R. & Hirsch, H. H. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 87, 621–630 (2009).
Smith, J. M. et al. A. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin. J. Am. Soc. Nephrol. 2, 1037–1042 (2007).
Mathur, V. S., Olson, J. L., Darragh, T. M. & Yen, T. S. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature. Am. J. Kidney Dis. 29, 754–758 (1997).
Drachenberg, C. B. et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am. J. Transplant. 4, 2082–2092 (2004).
Nickeleit, V. et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J. Am. Soc. Nephrol. 10, 1080–1089 (1999).
Binet, I. et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67, 918–922 (1999).
Hirsch, H. H. et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79, 1277–1286 (2005).
Drachenberg, C. B. et al. Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum. Pathol. 30, 970–977 (1999).
Nickeleit, V. et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol. Dial. Transplant. 15, 324–332 (2000).
Drachenberg, R. C. et al. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am. J. Transplant. 1, 373–381 (2001).
Koukoulaki, M. et al. Prospective study of urine cytology screening for BK polyoma virus replication in renal transplant recipients. Cytopathology 19, 385–388 (2008).
Brennan, D. C. et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am. J. Transplant. 5, 582–594 (2005).
Babel, N. et al. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples. Transplantation 88, 89–95 (2009).
Dadhania, D. et al. Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation 86, 521–528 (2008).
Costa, C. et al. Monitoring of BK virus replication in the first year following renal transplantation. Nephrol. Dial. Transplant. 23, 3333–3336 (2008).
Pang, X. L. et al. Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study. J. Clin. Microbiol. 45, 3568–3573 (2007).
Bressollette-Bodin, C. et al. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am. J. Transplant. 5, 1926–1933 (2005).
Hoffman, N. G. et al. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J. Clin. Microbiol. 46, 2671–2680 (2008).
Pang, X. L., Martin, K. & Preiksaitis, J. K. The use of unprocessed urine samples for detecting and monitoring BK viruses in renal transplant recipients by a quantitative real-time PCR assay. J. Virol. Methods 149, 118–122 (2008).
Bergallo, M. et al. Evaluation of six methods for extraction and purification of viral DNA from urine and serum samples. New Microbiol. 29, 111–119 (2006).
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant. 9 (Suppl. 3), S44–S58 (2009).
Bunde, T. et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201, 1031–1036 (2005).
Egli, A. et al. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. J. Transl. Med. 6, 29 (2008).
Meij, P. et al. Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood 101, 4290–4297 (2003).
Nickel, P. et al. High levels of CMV-I E-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Transpl. Immunol. 20, 238–242 (2009).
Sato, T. et al. Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients. Clin. Nephrol. 70, 393–403 (2008).
Ginevri, F. et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am. J. Transplant. 7, 2727–2735 (2007).
Bohl, D. L. et al. BK virus antibody titers and intensity of infections after renal transplantation. J. Clin. Virol. 43, 184–189 (2008).
Hariharan, S. et al. BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am. J. Transplant. 5, 2719–2724 (2005).
Ginevri, F. et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 75, 1266–1270 (2003).
Comoli, P., Binggeli, S., Ginevri, F. & Hirsch, H. H. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl. Infect. Dis. 8, 86–94 (2006).
Randhawa, P. et al. Longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin. Vaccine Immunol. 15, 1564–1571 (2008).
Gardner, S. D., MacKenzie, E. F., Smith, C. & Porter, A. A. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J. Clin. Pathol. 37, 578–586 (1984).
Rosen, S. et al. Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N. Engl. J. Med. 308, 1192–1196 (1983).
Andrews, C. A. et al. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J. Infect. Dis. 158, 176–181 (1988).
Bohl, D. L. et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am. J. Transplant. 5, 2213–2221 (2005).
Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872–874 (2004).
Awadalla, Y. et al. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am. J. Transplant. 4, 1691–1696 (2004).
Awadallah, Y., Duquesnoy, R., Randhawa, P. & Shapiro, R. HLA susceptibility to BKV infection. Am. J. Transplant. 6, 640; author reply 641 (2006).
Stern, M. et al. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients. Am. J. Transplant. 8, 1312–1317 (2008).
Womer, K. L. et al. The effects of renal transplantation on peripheral blood dendritic cells. Clin. Transplant. 19, 659–667 (2005).
Womer, K. L. et al. Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients. Transplantation 89, 115–123 (2010).
Binggeli, S. et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am. J. Transplant. 7, 1131–1139 (2007).
Zhou, W. et al. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunol. 20, 379–388 (2007).
Comoli, P., Hirsch, H. H. & Ginevri, F. Cellular immune responses to BK virus. Curr. Opin. Organ Transplant. 13, 569–574 (2008).
Hammer, M. H. et al. HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity. Am. J. Transplant. 6, 625–631 (2006).
Prosser, S. E. et al. Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis. Transplantation 85, 185–192 (2008).
Müller, K. et al. BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation doi:10.1097/TP.0b013e3181fe1335.
Babel, N. et al. Modification of immunosuppression can enhance the reconstitution of BKV-specific immunity preventing graft failure due to BKV-associated nephropathy in renal transplant patients. Transplantation 90 (Suppl.) 162 (2010).
Mueller, K. et al. BKV-specific polyfunctional and single IFNγ-producing T cells might determine the clinical course of BKV infection in renal transplant patients [abstract 14.441]. Am. J. Transplant. 10 (Suppl. 4) 450 (2010).
Han Lee, E. D. et al. A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am. J. Transplant. 6, 913–922 (2006).
Randhawa, P. S. et al. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 73, 1090–1094 (2002).
Prosch, S. et al. Human cytomegalovirus reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and mature monocytes. Intervirology 42, 308–313 (1999).
Randhawa, P. et al. Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int. 64, 743–747 (2003).
Hirsch, H. H. et al. Prospective study of Polyomavirus BK viruria and viremia in the de novo renal transplantation comparing cyclosporine and tacrolimus: a multivariate analysis [abstract #505]. Am. J. Transplant. 9 (Suppl. 2), 337 (2009).
Schold, J. D. et al. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl. Int. 22, 626–634 (2009).
Egli, A., Köhli, S., Dickenmann, M. & Hirsch, H. H. Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. Transplantation 88, 1161–1168 (2009).
Hardinger, K. L. et al. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am. J. Transplant. 10, 407–415 (2010).
Limaye, A. P. et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am. J. Transplant. 5, 614–620 (2005).
Atencio, I. A. et al. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J. Virol. 67, 1424–1432 (1993).
Loeches, B. et al. BK virus in liver transplant recipients: a prospective study. Transplant Proc. 41, 1033–1037 (2009).
Muñoz, P. et al. Prevalence of BK virus replication among recipients of solid organ transplants. Clin. Infect. Dis. 41, 1720–1725 (2005).
Andrews, C. A., Daniel, R. W. & Shah, K. V. Serologic studies of papovavirus infections in pregnant women and renal transplant recipients. Prog. Clin. Biol. Res. 105, 133–141 (1983).
Celik, B., Shapiro, R., Vats, A. & Randhawa, P. S. Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am. J. Transplant. 3, 1378–1382 (2003).
Shah, T. et al. Impact of BK virus treatment on adult kidney transplant recipient—an analysis of OPTN/UNOS database [abstract 291]. Am. J. Transplant. 9 (Suppl. 2), 275 (2009).
Johnston, O. et al. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation 89, 1057–1070 (2010).
Alméras, C. et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 85, 1099–1104 (2008).
Hymes, L. C. & Warshaw, B. L. Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis. Pediatr. Transplant. 10, 920–922 (2006).
Author information
Authors and Affiliations
Contributions
N. Babel researched the data for and wrote the article and provided a substantial contribution to discussions of the content, review and/or editing of the manuscript before submission. H. D. Volk and P. Reinke contributed equally to discussions of the content and to review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Babel, N., Volk, HD. & Reinke, P. BK polyomavirus infection and nephropathy: the virus–immune system interplay. Nat Rev Nephrol 7, 399–406 (2011). https://doi.org/10.1038/nrneph.2011.59
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2011.59
This article is cited by
-
Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review
BMC Infectious Diseases (2023)
-
Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients
Journal of Nephrology (2021)
-
Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology
Laboratory Investigation (2016)
-
Viral infections in prostate carcinomas in Chilean patients
Infectious Agents and Cancer (2015)
-
A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients
Kidney International (2015)